Evidence map›Paper›PMID 40709494›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Tau, atrophy, and domain-specific cognitive impairment in typical Alzheimer's disease.

Anika Wuestefeld, Long Xie, Emily McGrew, Alexa Pichet-Binette, Nicola Spotorno, Danielle van Westen, Niklas Mattsson-Carlgren, Paul A Yushkevich, Sandhitsu R Das, David A Wolk and 2 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Tau, atrophy, and domain-specific cognitive impairment in typical Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anika WuestefeldClinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0003-1779-3388
Long XiePenn Image Computing and Science Laboratory (PICSL), University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-7184-7028
Emily McGrewPenn Image Computing and Science Laboratory (PICSL), University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Alexa Pichet-BinetteClinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0001-5218-3337
Nicola SpotornoClinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0001-5404-8788
Danielle van WestenDepartment of Clinical Sciences Lund, Lund University, Lunds Universitet/SUS/Lund, Lund, Sweden.
Niklas Mattsson-CarlgrenClinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0002-8885-7724
Paul A YushkevichPenn Image Computing and Science Laboratory (PICSL), University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-8543-4016
Sandhitsu R DasDepartment of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-0530-2887
David A WolkDepartment of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-3554-3481
Laura E M WisseDepartment of Clinical Sciences Lund, Lund University, Lunds Universitet/SUS/Lund, Lund, Sweden.ORCID https://orcid.org/0000-0001-7504-3943
and for the Alzheimer's Disease Neuroimaging Initiative

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI Duygu Tosun-Turgut · 2016 to 2026
$226.7M
Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DAVID A WOLK · 2021 to 2026
$24.8M
Ex Vivo Imaging of the Aging Brain to Discover Morphology/Pathology AssociationsR01AG056014 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Paul A. Yushkevich · 2017 to 2026
$4.5M
A harmonized medial temporal lobe subregion segmentation protocol: an essential element for dementia researchR01AG070592 · NIA · WAYNE STATE UNIVERSITY · PI Ana Marie Daugherty, Rosanna Kathleen Olsen · 2022 to 2026
$3.5M
Improving the sensitivity and specificity of MRI-based biomarkers in Alzheimer's diseaseRF1AG069474 · NIA · UNIVERSITY OF PENNSYLVANIA · PI WOLK, DAVID A, YUSHKEVICH, PAUL A. · 2021 to 2021
$2.1M
Ex Vivo Imaging of the Aging Brain to Discover Morphology/Pathology AssociationsRF1AG056014 · NIA · UNIVERSITY OF PENNSYLVANIA · PI YUSHKEVICH, PAUL A. · 2023 to 2023
$2.1M
Improving the sensitivity and specificity of MRI-based biomarkers in Alzheimer's diseaseR01AG069474 · NIA · UNIVERSITY OF PENNSYLVANIA · PI WOLK, DAVID A, YUSHKEVICH, PAUL A. · 2024 to 2025
$1.4M
Bente Rexed Gerstedt FoundationDepartment of Defense W81XWH-12-2-0012MultiPark - A Strategic Research Area at Lund UniversityNIA NIH HHS P30 AG072979NIA NIH HHS P30-AG072979NIA NIH HHS R01 AG056014NIA NIH HHS R01 AG069474NIA NIH HHS R01-AG069474NIA NIH HHS R01 AG070592NIA NIH HHS R01-AG070592NIA NIH HHS RF1 AG056014NIA NIH HHS RF1-AG056014NIA NIH HHS RF1 AG069474NIA NIH HHS U01 AG024904NIA NIH HHS U19 AG024904NIA NIH HHS U19-AG024904NIH HHS U01 AG024904Stiftelsen För Gamla Tjänarinnor 2024-250Vetenskapsrådet 2022-00900
6 · The paper itself

Abstract

introductionA granular understanding of the mechanisms linking tau pathology to cognitive decline in Alzheimer's disease is crucial. We investigate mediating effects of medial temporal lobe (MTL) and neocortical neurodegeneration on tau-induced domain-specific cognitive impairment in amyloid-beta (Aβ) positive cognitively normal and impaired adults.

methodsWe assessed magnetic resonance imaging-derived MTL and neocortical volume/thickness and

resultsMTL tau correlated with memory subdomains, neocortical tau with executive function, and both with semantic fluency. Specific structural measures partially mediated these tau-cognition associations: Brodmann area 35 mediated tau-immediate and tau-delayed recall, posterior hippocampus tau-recognition, and inferior temporal cortex tau-semantic fluency associations. DISCUSSION: Our findings provide a nuanced understanding of region-specific macrostructural atrophy as one pathway of tau-induced cognitive changes, aligning with known tau spread patterns. Additionally, isolating cognitive functions is a promising approach for future research. HIGHLIGHTS: Medial temporal lobe tau was related to memory domains; neocortical tau to executive function. Both tau positron emission tomography measures were associated with semantic fluency. Specific regional atrophy partially mediated tau-induced cognitive changes. Other mechanistic links between tau and cognitive subdomains require investigation. Isolated cognitive domains should be explored as future avenues of research.

Indexed as

Alzheimer DiseaseCognitive Dysfunctiontau ProteinsTemporal LobeAgedAmyloid beta-PeptidesAtrophyFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeocortexNeuropsychological TestsPositron-Emission TomographyAmyloid beta-Peptidestau Proteinsamyloid‐betacognitive subdomainsin vivomagnetic resonance imagingmedial temporal lobe subregionsmediationtau positron emission tomographytypical Alzheimer's disease

Identifiers

PMID40709494
PMCPMC12290488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.